PTCT
Ptc Therapeutics·NASDAQ
--
--(--)
--
--(--)
PTCT fundamentals
During Q4 2025, Ptc Therapeutics (PTCT) reported revenue of 164.68M, a YoY change of -22.75%. Net income was -134.97M, a YoY change of -104.85%. Click to view the full income statement and explore the company's earnings performance.
Income Statement
Q1,2016 | Q2,2016 | Q3,2016 | Q4,2016 | Q1,2017 | Q2,2017 | Q3,2017 | Q4,2017 | Q1,2018 | Q2,2018 | Q3,2018 | Q4,2018 | Q1,2019 | Q2,2019 | Q3,2019 | Q4,2019 | Q1,2020 | Q2,2020 | Q3,2020 | Q4,2020 | Q1,2021 | Q2,2021 | Q3,2021 | Q4,2021 | Q1,2022 | Q2,2022 | Q3,2022 | Q4,2022 | Q1,2023 | Q2,2023 | Q3,2023 | Q4,2023 | Q1,2024 | Q2,2024 | Q3,2024 | Q4,2024 | Q1,2025 | Q2,2025 | Q3,2025 | Q4,2025 | TTM |
|---|
Start Date | Jan 1, 2016 | Apr 1, 2016 | Jul 1, 2016 | Oct 1, 2016 | Jan 1, 2017 | Apr 1, 2017 | Jul 1, 2017 | Oct 1, 2017 | Jan 1, 2018 | Apr 1, 2018 | Jul 1, 2018 | Oct 1, 2018 | Jan 1, 2019 | Apr 1, 2019 | Jul 1, 2019 | Oct 1, 2019 | Jan 1, 2020 | Apr 1, 2020 | Jul 1, 2020 | Oct 1, 2020 | Jan 1, 2021 | Apr 1, 2021 | Jul 1, 2021 | Oct 1, 2021 | Jan 1, 2022 | Apr 1, 2022 | Jul 1, 2022 | Oct 1, 2022 | Jan 1, 2023 | Apr 1, 2023 | Jul 1, 2023 | Oct 1, 2023 | Jan 1, 2024 | Apr 1, 2024 | Jul 1, 2024 | Oct 1, 2024 | Jan 1, 2025 | Apr 1, 2025 | Jul 1, 2025 | Oct 1, 2025 | -- |
End Date | Mar 31, 2016 | Jun 30, 2016 | Sep 30, 2016 | Dec 31, 2016 | Mar 31, 2017 | Jun 30, 2017 | Sep 30, 2017 | Dec 31, 2017 | Mar 31, 2018 | Jun 30, 2018 | Sep 30, 2018 | Dec 31, 2018 | Mar 31, 2019 | Jun 30, 2019 | Sep 30, 2019 | Dec 31, 2019 | Mar 31, 2020 | Jun 30, 2020 | Sep 30, 2020 | Dec 31, 2020 | Mar 31, 2021 | Jun 30, 2021 | Sep 30, 2021 | Dec 31, 2021 | Mar 31, 2022 | Jun 30, 2022 | Sep 30, 2022 | Dec 31, 2022 | Mar 31, 2023 | Jun 30, 2023 | Sep 30, 2023 | Dec 31, 2023 | Mar 31, 2024 | Jun 30, 2024 | Sep 30, 2024 | Dec 31, 2024 | Mar 31, 2025 | Jun 30, 2025 | Sep 30, 2025 | Dec 31, 2025 | -- |
Fiscal Year-End | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | -- |
Revenue | 18.89M +152.54% | 15.63M +130.78% | 22.99M +135.13% | 25.19M +97.82% | 26.55M +40.50% | 47.96M +206.80% | 41.85M +82.08% | 78.03M +209.75% | 56.06M +111.18% | 68.74M +43.33% | 53.59M +28.05% | 86.34M +10.65% | 53.58M -4.42% | 85.52M +24.41% | 71.42M +33.26% | 96.46M +11.72% | 68.26M +27.39% | 75.24M -12.02% | 118.40M +65.79% | 118.86M +23.23% | 117.94M +72.79% | 116.68M +55.07% | 138.74M +17.18% | 165.23M +39.01% | 148.74M +26.11% | 165.53M +41.87% | 217.13M +56.50% | 167.41M +1.32% | 220.38M +48.17% | 213.81M +29.17% | 196.58M -9.46% | 307.06M +83.41% | 210.12M -4.66% | 186.70M -12.68% | 196.79M +0.11% | 213.17M -30.58% | 1.18B +459.73% | 178.88M -4.19% | 211.01M +7.23% | 164.68M -22.75% | 1.73B -- |
Sales and Services Revenue | 18.89M +152.54% | 15.63M +130.78% | 22.99M +135.13% | 25.19M +97.82% | 26.55M +40.50% | 47.96M +206.80% | 41.85M +82.08% | 78.03M +209.75% | 56.06M +111.18% | 68.74M +43.33% | 53.59M +28.05% | 86.34M +10.65% | 53.58M -4.42% | 85.52M +24.41% | 71.42M +33.26% | 96.46M +11.72% | 68.26M +27.39% | 75.24M -12.02% | 118.40M +65.79% | 118.86M +23.23% | 117.94M +72.79% | 116.68M +55.07% | 138.74M +17.18% | 165.23M +39.01% | 148.74M +26.11% | 165.53M +41.87% | 217.13M +56.50% | 167.41M +1.32% | 220.38M +48.17% | 213.81M +29.17% | 196.58M -9.46% | 307.06M +83.41% | 210.12M -4.66% | 186.70M -12.68% | 196.79M +0.11% | 213.17M -30.58% | 1.18B +459.73% | 178.88M -4.19% | 211.01M +7.23% | 164.68M -22.75% | 1.73B -- |
Cost of Revenue | -- -- | -- -- | -- -- | 0 -- | 39.00K -- | 758.00K -- | 1.58M -- | 2.44M -- | 3.04M +7707.69% | 2.57M +239.31% | 3.29M +108.09% | 3.76M +54.46% | 2.38M -21.97% | 3.21M +24.84% | 3.01M -8.69% | 3.54M -5.82% | 4.08M +71.93% | 5.30M +65.18% | 4.67M +55.26% | 4.89M +37.94% | 9.10M +122.86% | 7.36M +38.73% | 6.54M +40.11% | 9.33M +90.89% | 10.13M +11.32% | 9.64M +31.00% | 14.01M +114.27% | 10.89M +16.79% | 14.14M +39.56% | 12.73M +32.08% | 9.49M -32.25% | 29.12M +167.31% | 14.74M +4.21% | 15.53M +21.96% | 10.85M +14.27% | 16.28M -44.08% | 12.86M -12.74% | 11.42M -26.45% | 15.78M +45.47% | 6.95M -57.32% | 47.01M -- |
Cost of Goods and Services | -- -- | -- -- | -- -- | 0 -- | -- -- | -- -- | -- -- | 4.58M -- | -- -- | -- -- | -- -- | 12.67M +176.82% | -- -- | -- -- | -- -- | 12.13M -4.22% | -- -- | -- -- | -- -- | 18.94M +56.09% | -- -- | -- -- | -- -- | 32.33M +70.67% | -- -- | -- -- | -- -- | 44.68M +38.20% | -- -- | -- -- | 9.49M -- | 29.12M -34.83% | 14.74M -- | 15.53M -- | 10.85M +14.27% | 16.28M -44.08% | 12.86M -12.74% | 11.42M -26.45% | 15.78M +45.47% | 6.95M -57.32% | 47.01M -- |
Gross Profit | 18.89M +152.54% | 15.63M +130.78% | 22.99M +135.13% | 25.19M +97.82% | 26.51M +40.29% | 47.20M +201.95% | 40.27M +75.20% | 75.59M +200.09% | 53.02M +100.00% | 66.17M +40.18% | 50.30M +24.90% | 82.58M +9.24% | 51.21M -3.41% | 82.31M +24.39% | 68.41M +36.01% | 92.92M +12.52% | 64.17M +25.32% | 69.94M -15.04% | 113.74M +66.26% | 113.98M +22.67% | 108.84M +69.60% | 109.32M +56.31% | 132.20M +16.24% | 155.90M +36.78% | 138.60M +27.35% | 155.89M +42.60% | 203.12M +53.64% | 156.52M +0.40% | 206.24M +48.80% | 201.08M +28.99% | 187.08M -7.89% | 277.94M +77.57% | 195.38M -5.27% | 171.18M -14.87% | 185.94M -0.61% | 196.89M -29.16% | 1.16B +495.38% | 167.46M -2.17% | 195.23M +5.00% | 157.73M -19.89% | 1.68B -- |
Other Operating Income | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | 0 -- | -- -- | -- -- | -- -- | 0 -- | -- -- | -- -- | -- -- | 500.00K -- | -- -- | -- -- | -- -- | 25.90M +5080.00% | -- -- | -- -- | -- -- | 2.70M -89.58% | 100.00K -- | -- -- | -- -- | 4.47M +65.74% | 800.00K +700.00% | -- -- | -- -- | 0 -100.00% | -- -- |
Operating Expenses | 57.34M +25.87% | 52.19M +14.96% | 55.05M +5.85% | 50.18M -17.65% | 52.86M -7.80% | 59.70M +14.39% | 71.16M +29.27% | 70.14M +39.78% | 69.76M +31.96% | 71.75M +20.17% | 98.53M +38.46% | 127.72M +82.07% | 120.35M +72.52% | 121.07M +68.75% | 128.88M +30.81% | 165.70M +29.74% | 157.16M +30.59% | 257.21M +112.45% | 168.87M +31.02% | 210.35M +26.95% | 206.99M +31.70% | 207.81M -19.21% | 225.28M +33.41% | 241.13M +14.63% | 225.12M +8.76% | 248.25M +19.46% | 271.30M +20.43% | 382.76M +58.73% | 323.85M +43.86% | 410.62M +65.41% | 305.25M +12.51% | 274.82M -28.20% | 240.93M -25.60% | 211.40M -48.52% | 240.45M -21.23% | 363.75M +32.36% | 193.81M -19.56% | 202.41M -4.25% | 192.21M -20.06% | 229.08M -37.02% | 817.51M -- |
Selling, General and Administrative Expenses | 25.94M +47.25% | 23.37M +35.77% | 23.65M +10.70% | 24.17M -6.62% | 25.50M -1.69% | 28.87M +23.54% | 41.14M +73.92% | 40.91M +69.25% | 38.40M +50.58% | 39.14M +35.59% | 44.16M +7.35% | 54.73M +33.77% | 46.62M +21.42% | 55.79M +42.55% | 56.31M +27.51% | 71.47M +30.59% | 66.16M +41.91% | 62.39M +11.83% | 67.47M +19.82% | 86.04M +20.38% | 72.37M +9.39% | 81.63M +30.84% | 83.64M +23.96% | 102.89M +19.58% | 96.74M +33.67% | 106.19M +30.08% | 111.14M +32.89% | 128.48M +24.88% | 126.33M +30.58% | 135.85M +27.93% | 139.53M +25.55% | 153.47M +19.44% | 124.80M -1.21% | 72.36M -46.73% | 76.49M -45.18% | 87.99M -42.66% | 84.76M -32.09% | 89.32M +23.43% | 91.58M +19.72% | 106.22M +20.72% | 371.88M -- |
Research and Development Expenses | 31.40M +12.39% | 28.83M +2.26% | 31.40M +2.47% | 26.01M -25.78% | 27.36M -12.85% | 30.84M +6.97% | 30.02M -4.37% | 29.23M +12.39% | 31.36M +14.62% | 32.61M +5.75% | 54.37M +81.08% | 53.65M +83.51% | 52.57M +67.61% | 59.98M +83.95% | 63.08M +16.02% | 81.83M +52.54% | 90.11M +71.42% | 176.53M +194.31% | 93.00M +47.44% | 118.01M +44.22% | 134.51M +49.28% | 125.48M -28.92% | 130.84M +40.70% | 149.84M +26.97% | 140.08M +4.14% | 157.26M +25.33% | 165.46M +26.46% | 188.69M +25.93% | 195.12M +39.30% | 185.87M +18.19% | 164.21M -0.76% | 121.35M -35.69% | 116.13M -40.48% | 132.17M -28.89% | 161.41M -1.71% | 124.77M +2.82% | 108.97M -6.16% | 112.99M -14.51% | 100.16M -37.95% | 133.13M +6.70% | 455.25M -- |
Loss on Impairment of Other Assets | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | 0 -- | -- -- | -- -- | -- -- | 0 -- | -- -- | -- -- | -- -- | 33.38M -- | -- -- | -- -- | 0 -- | 0 -100.00% | -- -- | -- -- | 1.84M -- | 155.94M -- | -- -- | -- -- | 472.00K -74.40% | -648.00K -100.42% | -- -- |
Loss on Disposal of Assets | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | 0 -- | -- -- | -- -- | 0 -- | 0 -- | 0 -- | 1.76M -- | -- -- | 750.00K -- | 77.00K -- | 99.00K -94.38% | -- -- | -9.63M -1383.60% | -- -- |
Other Operating Expenses | -- -- | -- -- | -- -- | 0 -- | -- -- | -- -- | -- -- | 0 -- | -- -- | -- -- | -- -- | 19.34M -- | 21.16M -- | 5.30M -- | 9.50M -- | 12.40M -35.88% | 900.00K -95.75% | 18.29M +245.15% | 8.40M -11.58% | 6.30M -49.19% | 100.00K -88.89% | 700.00K -96.17% | 10.80M +28.57% | -11.60M -284.13% | -11.70M -11800.00% | -15.20M -2271.43% | -5.30M -149.07% | 32.20M +377.59% | 2.40M +120.51% | 88.90M +684.87% | 1.50M +128.30% | -- -- | -- -- | 5.10M -94.26% | 700.00K -53.33% | -5.70M -- | -- -- | 0 -100.00% | 0 -100.00% | -- -- | -- -- |
Operating Income | -38.44M -0.97% | -36.56M +5.35% | -32.06M +24.08% | -24.99M +48.15% | -26.36M +31.44% | -12.50M +65.82% | -30.89M +3.66% | 5.45M +121.81% | -16.74M +36.47% | -5.57M +55.40% | -48.23M -56.12% | -45.14M -928.22% | -69.14M -312.95% | -38.76M -595.34% | -60.48M -25.39% | -72.78M -61.25% | -92.99M -34.50% | -187.27M -383.19% | -55.13M +8.84% | -96.37M -32.41% | -98.15M -5.55% | -98.49M +47.41% | -93.08M -68.83% | -84.73M +12.08% | -86.52M +11.85% | -92.36M +6.22% | -68.19M +26.74% | -200.34M -136.45% | -117.61M -35.94% | -209.54M -126.87% | -118.16M -73.29% | 5.82M +102.91% | -45.45M +61.35% | -40.22M +80.81% | -54.51M +53.87% | -162.39M -2890.19% | 970.23M +2234.57% | -34.96M +13.08% | 3.02M +105.53% | -71.35M +56.06% | 866.93M -- |
Non-Operating Income (Loss) | -2.68M -1816.03% | -2.45M -696.83% | -2.92M -223.26% | -1.44M +42.24% | -2.54M +5.23% | -4.83M -97.30% | -2.65M +9.04% | -3.35M -132.62% | -2.30M +9.38% | -3.56M +26.33% | -2.38M +10.21% | -4.18M -24.85% | -2.40M -4.26% | -2.26M +36.55% | 134.00K +105.62% | 5.75M +237.42% | -19.47M -712.43% | 5.93M +362.74% | 7.73M +5666.42% | 34.65M +502.57% | -30.04M -54.27% | -19.39M -426.96% | -40.58M -625.22% | -53.88M -255.47% | -35.37M -17.73% | -56.33M -190.54% | -59.02M -45.43% | 10.65M +119.76% | -17.38M +50.88% | -27.94M +50.41% | -48.43M +17.95% | -162.87M -1629.59% | -39.24M -125.86% | -45.52M -62.93% | -43.48M +10.21% | 67.69M +141.56% | -40.40M -2.94% | -36.09M +20.70% | -26.09M +40.00% | -67.73M -200.07% | -170.32M -- |
Other Non-Operating Income (Loss) | -721.00K -95.92% | -387.00K -339.77% | -786.00K -1441.18% | 686.00K +1533.33% | -318.00K +55.89% | -1.82M -370.28% | 766.00K +197.46% | 94.00K -86.30% | 1.00M +415.72% | -673.00K +63.02% | 734.00K -4.18% | -937.00K -1096.81% | -109.00K -110.86% | -183.00K +72.81% | 2.80M +281.47% | 11.21M +1296.80% | -13.83M -12589.91% | 11.31M +6279.78% | 28.77M +927.36% | 58.95M +425.65% | -10.88M +21.31% | 3.17M -71.97% | -18.78M -165.29% | -31.38M -153.23% | -11.86M -8.92% | -34.36M -1183.82% | -38.14M -103.07% | 35.15M +212.02% | 9.96M +183.98% | 1.48M +104.30% | -20.27M +46.87% | -118.60M -437.42% | 1.59M -84.02% | -2.02M -236.92% | -1.87M +90.76% | 108.75M +191.70% | -6.30M -496.29% | -5.74M -183.31% | 6.50M +447.33% | -12.55M -111.54% | -18.09M -- |
Net Interest Expense | 1.96M +473.28% | 2.06M +513.65% | 2.13M +150.35% | 2.13M -16.16% | 2.22M +13.45% | 3.01M +46.02% | 3.42M +60.38% | 3.45M +62.01% | 3.30M +48.85% | 2.88M -4.12% | 3.12M -8.86% | 3.25M -5.75% | 2.29M -30.73% | 2.07M -28.09% | 2.67M -14.50% | 5.46M +68.20% | 5.64M +146.59% | 5.38M +159.35% | 21.04M +689.16% | 24.29M +344.66% | 19.16M +239.58% | 22.56M +319.39% | 21.80M +3.63% | 22.50M -7.37% | 23.51M +22.73% | 21.98M -2.58% | 20.88M -4.23% | 24.50M +8.88% | 27.33M +16.23% | 29.41M +33.85% | 28.16M +34.87% | 44.27M +80.71% | 40.83M +49.41% | 43.49M +47.85% | 41.61M +47.76% | 41.06M -7.26% | 34.09M -16.51% | 30.36M -30.20% | 32.59M -21.67% | 55.19M +34.41% | 152.23M -- |
Interest Expense | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | 86.02M -- | -- -- | -- -- | -- -- | 90.87M +5.64% | -- -- | -- -- | 28.16M -- | 44.27M -51.28% | 40.83M -- | 43.49M -- | -- -- | 166.99M +277.17% | 34.09M -16.51% | 30.36M -30.20% | -- -- | 152.23M -8.84% | -- -- |
Pretax Income From Continuing Operations | -41.12M -8.45% | -39.01M -2.07% | -34.98M +18.90% | -26.43M +47.86% | -28.89M +29.74% | -17.32M +55.58% | -33.55M +4.10% | 2.10M +107.94% | -19.04M +34.09% | -9.13M +47.30% | -50.61M -50.87% | -49.32M -2450.95% | -71.54M -275.68% | -41.02M -349.18% | -60.34M -19.22% | -67.03M -35.91% | -112.47M -57.21% | -181.34M -342.14% | -47.40M +21.44% | -61.72M +7.93% | -128.19M -13.98% | -117.88M +35.00% | -133.66M -181.96% | -138.61M -124.58% | -121.89M +4.91% | -148.69M -26.14% | -127.21M +4.83% | -189.69M -36.86% | -134.99M -10.75% | -237.48M -59.71% | -166.59M -30.96% | -157.05M +17.21% | -84.70M +37.26% | -85.73M +63.90% | -97.99M +41.18% | -94.70M +39.70% | 929.83M +1197.84% | -71.05M +17.12% | -23.07M +76.45% | -139.08M -46.87% | 696.62M -- |
Income Tax Expense | 114.00K -- | -93.00K -164.14% | 184.00K +109.09% | 363.00K +44.05% | 165.00K +44.74% | 150.00K +261.29% | 191.00K +3.80% | 828.00K +128.10% | 221.00K +33.94% | 389.00K +159.33% | 355.00K +85.86% | -993.00K -219.93% | 576.00K +160.63% | 774.00K +98.97% | -344.00K -196.90% | 10.64M +1171.90% | 222.00K -61.46% | 84.00K -89.15% | 22.29M +6579.07% | 12.63M +18.70% | 451.00K +103.15% | 488.00K +480.95% | -36.00K -100.16% | 4.66M -63.14% | 4.83M +972.06% | 3.39M +595.08% | -17.89M -49602.78% | -18.80M -503.78% | 3.97M -17.91% | -38.60M -1237.85% | -33.62M -87.89% | -1.26M +93.30% | 6.88M +73.34% | 13.45M +134.84% | 8.66M +125.77% | -28.81M -2188.56% | 63.27M +819.56% | -6.20M -146.13% | -38.97M -549.84% | -4.12M +85.71% | 13.97M -- |
Current Income Tax | -- -- | -- -- | -- -- | 768.00K +58.35% | -- -- | -- -- | -- -- | 1.14M +48.05% | -- -- | -- -- | -- -- | 707.00K -37.82% | -- -- | -- -- | -- -- | 2.10M +197.31% | -- -- | -- -- | -- -- | 29.36M +1296.57% | -- -- | -- -- | -- -- | 5.18M -82.34% | -- -- | -- -- | -- -- | 5.81M +12.00% | -- -- | -- -- | -- -- | -23.22M -499.98% | -- -- | -- -- | -- -- | 55.11M +337.32% | -- -- | -- -- | -- -- | 12.99M -76.42% | -- -- |
Deferred Income Tax | -- -- | -- -- | -- -- | -199.00K -- | -- -- | -- -- | -- -- | 198.00K +199.50% | -- -- | -- -- | -- -- | -736.00K -471.72% | -- -- | -- -- | -- -- | 9.55M +1397.28% | -- -- | -- -- | -- -- | 5.87M -38.50% | -- -- | -- -- | -- -- | 377.00K -93.58% | -- -- | -- -- | -- -- | -34.28M -9191.78% | -- -- | -- -- | -- -- | -46.28M -35.03% | -- -- | -- -- | -- -- | -54.94M -18.70% | -- -- | -- -- | -- -- | 980.00K +101.78% | -- -- |
Net Income | -41.23M -8.75% | -38.91M -1.44% | -35.17M +18.64% | -26.80M +47.41% | -29.06M +29.53% | -17.48M +55.09% | -33.74M +4.06% | 1.27M +104.74% | -19.26M +33.71% | -9.52M +45.52% | -50.97M -51.07% | -48.33M -3905.51% | -72.11M -274.36% | -41.79M -338.96% | -60.00M -17.71% | -77.68M -60.72% | -112.69M -56.26% | -181.43M -334.15% | -69.69M -16.16% | -74.35M +4.28% | -128.64M -14.16% | -118.37M +34.76% | -133.62M -91.74% | -143.26M -92.68% | -126.73M +1.49% | -152.09M -28.48% | -109.31M +18.19% | -170.89M -19.28% | -138.96M -9.65% | -198.88M -30.77% | -132.97M -21.64% | -155.79M +8.83% | -91.58M +34.10% | -99.18M +50.13% | -106.65M +19.79% | -65.89M +57.71% | 866.56M +1046.28% | -64.85M +34.61% | 15.90M +114.90% | -134.97M -104.85% | 682.64M -- |
Net Income Attributable to Owners of the Company | -41.23M -8.75% | -38.91M -1.44% | -35.17M +18.64% | -26.80M +47.41% | -29.06M +29.53% | -17.48M +55.09% | -33.74M +4.06% | 1.27M +104.74% | -19.26M +33.71% | -9.52M +45.52% | -50.97M -51.07% | -48.33M -3905.51% | -72.11M -274.36% | -41.79M -338.96% | -60.00M -17.71% | -77.68M -60.72% | -112.69M -56.26% | -181.43M -334.15% | -69.69M -16.16% | -74.35M +4.28% | -128.64M -14.16% | -118.37M +34.76% | -133.62M -91.74% | -143.26M -92.68% | -126.73M +1.49% | -152.09M -28.48% | -109.31M +18.19% | -170.89M -19.28% | -138.96M -9.65% | -198.88M -30.77% | -132.97M -21.64% | -155.79M +8.83% | -91.58M +34.10% | -99.18M +50.13% | -106.65M +19.79% | -65.89M +57.71% | 866.56M +1046.28% | -64.85M +34.61% | 15.90M +114.90% | -134.97M -104.85% | 682.64M -- |
Net Income Attributable to Common Stockholders | -41.23M -8.75% | -38.91M -1.44% | -35.17M +18.64% | -26.80M +47.41% | -29.06M +29.53% | -17.48M +55.09% | -33.74M +4.06% | 1.27M +104.74% | -19.26M +33.71% | -9.52M +45.52% | -50.97M -51.07% | -48.33M -3905.51% | -72.11M -274.36% | -41.79M -338.96% | -60.00M -17.71% | -77.68M -60.72% | -112.69M -56.26% | -181.43M -334.15% | -69.69M -16.16% | -74.35M +4.28% | -128.64M -14.16% | -118.37M +34.76% | -133.62M -91.74% | -143.26M -92.68% | -126.73M +1.49% | -152.09M -28.48% | -109.31M +18.19% | -170.89M -19.28% | -138.96M -9.65% | -198.88M -30.77% | -132.97M -21.64% | -155.79M +8.83% | -91.58M +34.10% | -99.18M +50.13% | -106.65M +19.79% | -65.89M +57.71% | 866.56M +1046.28% | -64.85M +34.61% | 15.90M +114.90% | -134.97M -104.85% | 682.64M -- |
Other Comprehensive Income | 2.28M +228300.00% | -199.00K -182.57% | -129.00K +79.59% | -2.24M -2969.86% | 609.00K -73.34% | 2.88M +1544.72% | 1.01M +886.05% | 956.00K +142.66% | 984.00K +61.58% | -3.10M -207.76% | -227.00K -122.39% | -166.00K -117.36% | -657.00K -166.77% | 1.12M +136.06% | -1.31M -475.33% | -11.20M -6646.99% | 8.60M +1408.83% | -8.03M -818.98% | -25.71M -1868.68% | -25.23M -125.27% | 22.21M +158.33% | -7.34M +8.55% | 13.13M +151.05% | 8.68M +134.40% | 5.67M -74.46% | 28.86M +492.96% | 25.95M +97.73% | -31.41M -461.90% | -6.38M -212.50% | 156.00K -99.46% | 11.04M -57.46% | -10.89M +65.32% | -4.28M +33.03% | -10.94M -7111.54% | 12.15M +10.10% | -21.54M -97.75% | 11.94M +379.23% | 21.30M +294.78% | -1.43M -111.73% | 4.57M +121.22% | 36.39M -- |
Total Comprehensive Income | -38.95M -2.73% | -39.11M -2.60% | -35.30M +19.52% | -29.04M +43.09% | -28.45M +26.96% | -14.60M +62.67% | -32.72M +7.29% | 2.23M +107.67% | -18.28M +35.75% | -12.62M +13.58% | -51.20M -56.45% | -48.50M -2278.62% | -72.77M -298.11% | -40.67M -222.33% | -61.30M -19.74% | -88.88M -83.27% | -104.09M -43.04% | -189.46M -365.82% | -95.40M -55.63% | -99.58M -12.05% | -106.43M -2.25% | -125.71M +33.65% | -120.50M -26.30% | -134.59M -35.15% | -121.05M -13.74% | -123.23M +1.98% | -83.36M +30.82% | -202.30M -50.31% | -145.34M -20.07% | -198.73M -61.27% | -121.93M -46.27% | -166.69M +17.60% | -95.85M +34.05% | -110.12M +44.59% | -94.50M +22.50% | -87.43M +47.55% | 878.50M +1016.53% | -43.54M +60.46% | 14.47M +115.31% | -130.39M -49.14% | 719.03M -- |
Total Comprehensive Income Attributable to Owners of the Company | -38.95M -2.73% | -39.11M -2.60% | -35.30M +19.52% | -29.04M +43.09% | -28.45M +26.96% | -14.60M +62.67% | -32.72M +7.29% | 2.23M +107.67% | -18.28M +35.75% | -12.62M +13.58% | -51.20M -56.45% | -48.50M -2278.62% | -72.77M -298.11% | -40.67M -222.33% | -61.30M -19.74% | -88.88M -83.27% | -104.09M -43.04% | -189.46M -365.82% | -95.40M -55.63% | -99.58M -12.05% | -106.43M -2.25% | -125.71M +33.65% | -120.50M -26.30% | -134.59M -35.15% | -121.05M -13.74% | -123.23M +1.98% | -83.36M +30.82% | -202.30M -50.31% | -145.34M -20.07% | -198.73M -61.27% | -121.93M -46.27% | -166.69M +17.60% | -95.85M +34.05% | -110.12M +44.59% | -94.50M +22.50% | -87.43M +47.55% | 878.50M +1016.53% | -43.54M +60.46% | 14.47M +115.31% | -130.39M -49.14% | 719.03M -- |
Basic EPS | -1.22 -6.09% | -1.14 -- | -1.03 +18.90% | -0.78 -- | -0.85 +30.33% | -0.44 +61.40% | -0.82 +20.39% | 0.03 +103.85% | -0.46 +45.88% | -0.21 +52.27% | -1.06 -29.27% | -0.95 -3266.67% | -1.29 -180.43% | -0.75 -257.14% | -1.06 -- | -1.25 -31.58% | -1.81 -40.31% | -2.78 -270.67% | -1.03 +2.83% | -1.07 +14.40% | -1.83 -1.10% | -1.68 +39.57% | -1.89 -83.50% | -2.02 -88.79% | -1.78 +2.73% | -2.13 -26.79% | -1.53 +19.05% | -2.34 -15.84% | -1.88 -5.62% | -2.66 -24.88% | -1.76 -15.03% | -2.06 +11.97% | -1.2 +36.17% | -1.29 +51.50% | -1.39 +21.02% | -0.85 +58.74% | 11.09 +1024.17% | -0.83 +35.66% | 0.2 +114.39% | -1.66 -95.29% | 8.8 -- |
Basic EPS from Continuing Operations | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -1.76 -- | -- -- | -1.2 -- | -1.29 -- | -1.39 +21.02% | -- -- | 11.09 +1024.17% | -0.83 +35.66% | 0.2 +114.39% | -- -- | -- -- |
Diluted EPS | -1.22 -6.09% | -1.14 -- | -1.03 +18.90% | -- -- | -0.85 +30.33% | -0.44 +61.40% | -0.82 +20.39% | -- -- | -0.46 +45.88% | -0.21 +52.27% | -1.06 -29.27% | -- -- | -1.29 -180.43% | -0.75 -257.14% | -1.06 -- | -- -- | -1.81 -40.31% | -2.78 -270.67% | -1.03 +2.83% | -- -- | -1.83 -1.10% | -1.68 +39.57% | -1.89 -83.50% | -- -- | -1.78 +2.73% | -2.13 -26.79% | -1.53 +19.05% | -- -- | -1.88 -5.62% | -2.66 -24.88% | -1.76 -15.03% | -- -- | -1.2 +36.17% | -1.29 +51.50% | -1.39 +21.02% | -- -- | 10.04 +936.67% | -0.83 +35.66% | 0.2 +114.39% | -- -- | -- -- |
Diluted EPS from Continuing Operations | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -1.76 -- | -- -- | -1.2 -- | -1.29 -- | -1.39 +21.02% | -- -- | 10.04 +936.67% | -0.83 +35.66% | 0.2 +114.39% | -- -- | -- -- |
You can ask Aime
What does Ptc Therapeutics do and what are its main business segments?What is the revenue and EPS growth rate for Ptc Therapeutics year over year?What factors drove the changes in Ptc Therapeutics's revenue and profit?What is Ptc Therapeutics's latest dividend and current dividend yield?What were the key takeaways from Ptc Therapeutics's earnings call?What is the market's earnings forecast for Ptc Therapeutics next quarter?Did Ptc Therapeutics beat or miss consensus estimates last quarter?What is Ptc Therapeutics's gross profit margin?
ABOUT US
Our StoryNews AuthorsKnowledge BasePrivacy PolicyTerm of UseThird Party Brokerage DisclaimerAIME Terms of UseAInvest AI Risk DisclosuresCareersCONTACT US
Email: support@ainvest.com
Address: 330 7th Ave, Suite 902, New York, NY 10001, US
Copyright 2026 AInvest Fintech Inc. All rights reserved.
